449
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Design and Evaluation of a Stearylated Multicomponent peptide-siRNA Nanocomplex for Efficient Cellular siRNA Delivery

, , &
Pages 281-293 | Received 06 Oct 2016, Accepted 05 Dec 2016, Published online: 17 Jan 2017

References

  • Pecot CV Calin GA Coleman RL Lopez-Berestein G Sood AK . RNA interference in the clinic: challenges and future directions . Nat. Rev. Cancer11 ( 1 ), 59 – 67 ( 2011 ).
  • Wittrup A Lieberman J . Knocking down disease: a progress report on siRNA therapeutics . Nat. Rev. Genet.16 ( 9 ), 543 – 552 ( 2015 ).
  • Oh YK Park TG . siRNA delivery systems for cancer treatment . Adv. Drug Deliv. Rev.61 ( 10 ), 850 – 862 ( 2009 ).
  • Lee SJ Kim MJ Kwon IC Roberts TM . Delivery strategies and potential targets for siRNA in major cancer types . Adv. Drug Deliv. Rev.104 , 2 – 15 ( 2016 ).
  • Thi EP Mire CE Lee AC et al. Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates . Nature521 ( 7552 ), 362 – 365 ( 2015 ).
  • Blake SJ Bokhari FF Mcmillan NA . RNA interference for viral infections . Curr. Drug Targets13 ( 11 ), 1411 – 1420 ( 2012 ).
  • Martinez T Wright N Lopez-Fraga M Jimenez AI Paneda C . Silencing human genetic diseases with oligonucleotide-based therapies . Hum. Genet.132 ( 5 ), 481 – 493 ( 2013 ).
  • Grinberg D . Recent patents relating to siRNAs and therapeutic strategies for genetic diseases . Recent Pat. DNA Gene Seq.2 ( 1 ), 40 – 43 ( 2008 ).
  • Hannon GJ . RNA interference . Nature418 ( 6894 ), 244 – 251 ( 2002 ).
  • Whitehead KA Langer R Anderson DG . Knocking down barriers: advances in siRNA delivery . Nat. Rev. Drug Discov.8 ( 2 ), 129 – 138 ( 2009 ).
  • Wang J Lu Z Wientjes MG Au JL . Delivery of siRNA therapeutics: barriers and carriers . AAPS J.12 ( 4 ), 492 – 503 ( 2010 ).
  • Schroeder A Levins CG Cortez C Langer R Anderson DG . Lipid-based nanotherapeutics for siRNA delivery . J. Intern. Med.267 ( 1 ), 9 – 21 ( 2010 ).
  • Gomes-Da-Silva LC Fonseca NA Moura V Pedroso De Lima MC Simoes S Moreira JN . Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges . Acc. Chem. Res.45 ( 7 ), 1163 – 1171 ( 2012 ).
  • Ardana A Whittaker AK Mcmillan NaJ Thurecht KJ . Polymeric siRNA delivery vectors: knocking down cancers with polymeric-based gene delivery systems . J. Chem. Technol. Biotechnol.90 ( 7 ), 1196 – 1208 ( 2015 ).
  • Wagner E . Polymers for siRNA delivery: inspired by viruses to be targeted, dynamic, and precise . Acc. Chem. Res.45 ( 7 ), 1005 – 1013 ( 2012 ).
  • Van Asbeck AH Beyerle A Mcneill H et al. Molecular parameters of siRNA – cell penetrating peptide nanocomplexes for efficient cellular delivery . ACS Nano7 ( 5 ), 3797 – 3807 ( 2013 ).
  • Raad M Teunissen EA Mastrobattista E . Peptide vectors for gene delivery: from single peptides to multifunctional peptide nanocarriers . Nanomedicine (Lond.)9 ( 14 ), 2217 – 2232 ( 2014 ).
  • Kanasty R Dorkin JR Vegas A Anderson D . Delivery materials for siRNA therapeutics . Nat. Mater.12 ( 11 ), 967 – 977 ( 2013 ).
  • Williford JM Wu J Ren Y Archang MM Leong KW Mao HQ . Recent advances in nanoparticle-mediated siRNA delivery . Annu. Rev. Biomed. Eng.16 , 347 – 370 ( 2014 ).
  • Lee SJ Huh MS Lee SY et al. Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic siRNA delivery in cancer treatment . Angew. Chem. Int. Ed. Engl.51 ( 29 ), 7203 – 7207 ( 2012 ).
  • Moghimi SM Symonds P Murray JC Hunter AC Debska G Szewczyk A . A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy . Mol. Ther.11 ( 6 ), 990 – 995 ( 2005 ).
  • Qin B Chen ZJ Jin W Cheng K . Development of cholesteryl peptide micelles for siRNA delivery . J. Control. Release172 ( 1 ), 159 – 168 ( 2013 ).
  • Nakase I Tanaka G Futaki S . Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells . Mol. Biosyst.9 ( 5 ), 855 – 861 ( 2013 ).
  • Dominska M Dykxhoorn DM . Breaking down the barriers: siRNA delivery and endosome escape . J. Cell Sci.123 ( Pt 8 ), 1183 – 1189 ( 2010 ).
  • Wan Y Moyle PM Toth I . Endosome escape strategies for improving the efficacy of oligonucleotide delivery systems . Curr. Med. Chem.22 ( 29 ), 3326 – 3346 ( 2015 ).
  • Wan Y Moyle PM Christie MP Toth I . Nanosized, peptide-based multicomponent DNA delivery systems: optimization of endosome escape activity . Nanomedicine (Lond.)11 ( 8 ), 907 – 919 ( 2016 ).
  • Tai Z Wang X Tian J et al. Biodegradable stearylated peptide with internal disulfide bonds for efficient delivery of siRNA in vitro and in vivo . Biomacromolecules16 ( 4 ), 1119 – 1130 ( 2015 ).
  • Pan R Xu W Yuan F et al. A novel peptide for efficient siRNA delivery in vitro and therapeutics in vivo . Acta Biomater.21 , 74 – 84 ( 2015 ).
  • Lehto T Abes R Oskolkov N et al. Delivery of nucleic acids with a stearylated (RxR)(4) peptide using a non-covalent co-incubation strategy . J. Control. Release141 ( 1 ), 42 – 51 ( 2010 ).
  • Schmittgen TD Livak KJ . Analyzing real-time PCR data by the comparative C(T) method . Nat. Protoc.3 ( 6 ), 1101 – 1108 ( 2008 ).
  • Schroeder A Dahlman JE Sahay G et al. Alkane-modified short polyethyleneimine for siRNA delivery . J. Control. Release160 ( 2 ), 172 – 176 ( 2012 ).
  • Qin B Chen Z Jin W Cheng K . Development of cholesteryl peptide micelles for siRNA delivery . J. Control. Release172 ( 1 ), 159 – 168 ( 2013 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.